Cost-effectiveness analysis of antiretroviral drugs for treatment-naive HIV infection in China

INTRODUCTION: Dolutegravir (DTG)-based regimen was included in the expanded formulary of China's National Free Antiretroviral Treatment Program at the end of 2021. Yet high price of DTG and lack of health economic evaluation in China present barriers for implementation of the regimen. The study...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Min, Cao, Yuxin, Huang, Hao, Qin, Gang, Chu, Minjie, Zou, Meiyin, Zhuang, Xun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641994/
https://www.ncbi.nlm.nih.gov/pubmed/37953277
http://dx.doi.org/10.1186/s12889-023-17052-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641994/
https://www.ncbi.nlm.nih.gov/pubmed/37953277
http://dx.doi.org/10.1186/s12889-023-17052-1

Ejemplares similares